Studies using genetic models of tissue-specific insulin resistance obtained by selectively knocking out insulin receptor genes with Cre-loxP technology have found differing effects on insulin resistance in different tissues during systemic metabolic disease (Kubota et al., 2017). The gene discussed is INSR; the disease is Insulin resistance.